ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,116.17
0.32%
US Tech 100
17,312.80
0.42%
Dow Jones
38,386.09
0.38%
Brent Oil
86.925
-0.41%
Bitcoin
63,436.83
-0.63%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Eupraxia Pharmaceuticals Inc (EPRX) Quote

Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc (EPRX)

Eupraxia Pharmaceuticals Inc
2.70
-0.0999
(-3.57%)
Closed April 30 4:00PM
Delayed by 15 minutes
2.70
0.00
(0.00%)
After Hours: 6:00PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
2.70
Bid
1.13
Ask
3.38
Volume
27,155
2.70 Day's Range 2.825
2.48 52 Week Range 3.55
Market Cap
100.398M
Previous Close
2.7999
Open
2.75
Last Trade
1
@
2.7
Last Trade Time
Financial Volume
$ 75,563
VWAP
2.7826
Average Volume (3m)
32,391
Shares Outstanding
27,282,000
Dividend Yield
-
PE Ratio
-3.56
Earnings Per Share (EPS)
-1.03
Revenue
-
Net Profit
-28.22M

About Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient be... Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.eupraxiapharma.com
Headquarters
Victoria, British Columbia, Can
Founded
1970
Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was $2.80. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of $ 2.48 to $ 3.55.

Eupraxia Pharmaceuticals currently has 27,282,000 shares outstanding. The market capitalization of Eupraxia Pharmaceuticals is $100.40 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -3.56.

EPRX Latest News

More News

Eupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024

Eupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024 Canada NewsWire VICTORIA, BC, April 11, 2024 VICTORIA, BC, April...

April 11 2024
PR Newswire (Canada)

Eupraxia Pharmaceuticals To Present at Bloom Burton & Co. Healthcare Investor Conference

Eupraxia Pharmaceuticals To Present at Bloom Burton & Co. Healthcare Investor Conference Canada NewsWire VICTORIA, BC, April 8, 2024 VICTORIA, BC, April 8, 2024 /CNW/ - Eupraxia...

April 08 2024
PR Newswire (Canada)

Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today

Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today Canada NewsWire VICTORIA, BC, April 5, 2024 VICTORIA, BC, April 5, 2024 /CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the...

April 05 2024
PR Newswire (Canada)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.06-2.173913043482.763.082.7202362.9504267CS
4-0.85-23.94366197183.553.552.48323912.85233173CS
12-0.85-23.94366197183.553.552.48323912.85233173CS
26-0.85-23.94366197183.553.552.48323912.85233173CS
52-0.85-23.94366197183.553.552.48323912.85233173CS
156-0.85-23.94366197183.553.552.48323912.85233173CS
260-0.85-23.94366197183.553.552.48323912.85233173CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSLRComplete Solaria Inc
$ 0.7303
(91.73%)
25.8M
MULNMullen Automotive Inc
$ 5.73
(81.33%)
72.12M
DCPHDeciphera Pharmaceuticals Inc
$ 25.28
(72.56%)
50.72M
CAUDCollective Audience Inc
$ 0.6377
(63.51%)
157.73M
LICNLichen China Limited
$ 2.03
(48.18%)
3.96M
CLVRClever Leaves Holdings Inc
$ 1.62
(-60.58%)
768.37k
ADXNAddex Therapeutics Ltd
$ 7.68
(-52.30%)
160.84k
TSDDGraniteShares ETF Trust GraniteShares
$ 17.1879
(-30.97%)
1.64M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 27.23
(-30.66%)
7.72M
MFImF International Ltd
$ 1.665
(-28.54%)
3.55M
TSLATesla Inc
$ 194.05
(15.31%)
243.77M
SINTSiNtx Technologies Inc
$ 0.053477
(32.37%)
174.36M
CAUDCollective Audience Inc
$ 0.6377
(63.51%)
157.73M
SOFISoFi Technologies Inc
$ 7.045
(-10.48%)
149.63M
SQQQProShares UltraPro Short QQQ
$ 11.31
(-1.05%)
97.67M

Discussion

View Full Feed
The Night Stalker The Night Stalker 45 seconds ago
green
EMED
vdog1776 vdog1776 2 minutes ago
I’m not worried you gullible fool!!!
INQD
uber darthium uber darthium 2 minutes ago
It would require a very small table and only open once a month. No more than 2 or 3 chairs…

They should open a restaurant....farm to table. Imo.
SHMP
Wise Man Wise Man 2 minutes ago
By the way, we see how judge Willett, in the previous screenshot, claimed that FnF had returned to sound condition at the time, referring to the return to profitability, when, in a financial company, soundness is related to the capital levels.
That is, RETAINED earnings (Core Capital).
FNMA
stervc stervc 2 minutes ago
Jaxxm, with these CBIA Updates...

Thanks for posting these CBIA updates regarding non dilutive financing and the pending acquisition of a very profitable private company:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174324225

I did take a start
CBIA
The Night Stalker The Night Stalker 3 minutes ago
on 0011
CAVR
The Night Stalker The Night Stalker 3 minutes ago
on 0011
CAVR
Juststoppingby Juststoppingby 3 minutes ago
When Molliitium and Armistice sell, the outstanding shares will increase, and the ownership percentage will drop.
CRTG
CrashOverride CrashOverride 3 minutes ago
I do not believe we should expect a buyout at the current valuation or anywhere near. In my opinion management feel the pain we know as shareholders which should be lessened significantly after UK approval.

While some members of the board and management are certainly old, younger s
NWBO
The Night Stalker The Night Stalker 4 minutes ago
how long
PWDY
devil dog 96 devil dog 96 5 minutes ago
More no proof nonsense. 🤡 I did not get 1 share today and my BID was higher than the BID that traders were being quoted. Tell us your thought on why everyone is holding so tight? Not only are the shareholders holding tight the insiders won't sell any either before the marketing begins. I don
ATMH
MonopolyTrader MonopolyTrader 5 minutes ago
Difference now is Jim persuaded people to buy “cheap” shares or “they aren’t going to get cheaper” or “we’re weeks away, it’s time” to many shareholders via phone or text.


He might be stuck. Does he screw everyone and keep issuing or reverse split it?

And take
GSTC
The Night Stalker The Night Stalker 6 minutes ago
there were pos sellers at BLEG but it did manage to run, lets see CEO further communiction to shareholders
BLEG
The Night Stalker The Night Stalker 6 minutes ago
there were pos sellers at BLEG but it did manage to run, lets see CEO further communiction to shareholders
BLEG
LuckyLovie LuckyLovie 8 minutes ago
Yes it's very difficult to hold 2 Big fun bags and hit submit,sprinkle in a rocking boat and loud music and its a challenge to post correctly on these scam stock plays..
GVSI
lucmariepierre lucmariepierre 8 minutes ago
C est le bon nombre le mien définitivement et le vôtre est le même

Air espace

00:01 00:01
nbvb
MonopolyTrader MonopolyTrader 10 minutes ago
Yup. what’s crazy is. Jim should pull up the retail shareholders list. He would be surprised who is holding.

I don’t see how Jim doesn’t get in trouble if this doesn’t go anywhere
GSTC
lodas lodas 11 minutes ago
and your contribution to America is what?....Lodas
COOP
silvr_surfr silvr_surfr 12 minutes ago
Here's a well-written article about testosterone for women. First time I have seen a reporter dig on this topic.

https://www.medpagetoday.com/obgyn/menopause/109693 Can Testosterone Aid Women's Menopause

Here's my favorite part:

When asked to elaborate
ANIP
rayovac812 rayovac812 12 minutes ago
KBLB's PR's are catered to a FINANCIERS audience.

Partly. Right now he has Vietnam and India as an audience too.

They very well know that longs want to hear of

PRODUCTION AND LOTS OF IT.

In due time.

THE ELUSIVE AT
KBLB
jay_tee jay_tee 12 minutes ago
Seamus won’t let his money machine go to the expert market. Just read up on a few things it seems to be more of a hassle to get out of the em versus just file before due dates.
RNVA
LuckyLovie LuckyLovie 13 minutes ago
Yup they like the pump,only way to make money with these scam stocks....if you or I raved about a despicable act human trafficking we'd be banned...I love how the clan all disappears when this thing plummets...their all full of chit "" yeah the reverse split will be awwwsome "" then LinkPest who dwe
GVSI
littlejohn littlejohn 13 minutes ago
Around $787 gap open from Friday didn't

fill on Monday...

If it doesn't fill on Tuesday, then

will be eyeing puts before close...

MMs marked the spot for retreat

for some reason during rebound after

dip expect
SMCI
The Night Stalker The Night Stalker 14 minutes ago
like this
GMZP

Your Recent History

NASDAQ
EPRX
Eupraxia Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved